netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 18 of 18


Details
UPD sitematrix Changed from 0 to
20/11/2023 12:47:47
(DavidS )
UPD FurtherInformation Changed from

 
20/11/2023 12:47:47
(DavidS )
UPD Dacomitinib (Vizimpro®) updated formatting
20/11/2023 12:47:47
(DavidS )
UPD sitematrix Changed from 0 to
27/07/2022 14:45:48
(DavidS )
UPD BlueTeq Changed from N to Y
27/07/2022 14:45:48
(DavidS )
UPD FurtherInformation Changed from

  • Approved as an option for untreated locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in adults in line with NICE

to

 
27/07/2022 14:45:48
(DavidS )
UPD Dacomitinib (Vizimpro®) updated
27/07/2022 14:45:48
(DavidS )
UPD sitematrix Changed from 0 to
26/04/2022 12:04:07
(DavidS )
UPD FurtherInformation Changed from

 
26/04/2022 12:04:07
(DavidS )
UPD Dacomitinib (Vizimpro®) updated
26/04/2022 12:04:07
(DavidS )
UPD sitematrix Changed from 0 to
26/04/2022 11:12:40
(DavidS )
UPD isCyto Changed from 0 to 1
26/04/2022 11:12:40
(DavidS )
UPD FurtherInformation Changed from

  • Approved as an option for untreated locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in adults in line with NICE

to

 
26/04/2022 11:12:40
(DavidS )
UPD Dacomitinib (Vizimpro®) updated
26/04/2022 11:12:40
(DavidS )
UPD Published from Draft Mode
14/11/2019 09:42:03
(LoweryM )
UPD Published from Draft Mode
14/11/2019 09:42:02
(LoweryM )
LDL Link Added : NICE TA595: Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancer : https://www.nice.org.uk/guidance/ta595
29/10/2019 14:42:40
(DavidS )
ADD Dacomitinib (Vizimpro®) add
29/10/2019 14:41:50
(DavidS )

 

 
netFormulary